October 31, 2016
New Research Aims to Increase Pancreatic Cancer Survival Rates
Two in five British Columbians will be diagnosed with cancer in their lifetime.
Dr. Miller is an internationally renowned surgeon, educator, clinician and researcher, and was one of the leaders in launching the world’s first population-based ovarian cancer prevention program.
Our focus involves a new lung cancer screening pilot programs at VGH along with new research programs to increase the survival rates of cancer. We are leaders in prostate, pancreatic, ovarian and blood cancers.
More than 1.6 million people
worldwide die each year from lung cancer.
6% survival rate
Pancreatic cancer is one of the deadliest cancers, affecting 1 in 79 Canadians with an average 6% survival rate.
Our initiatives are driven with the hopes to lead to changes in clinical care and the formation of public policy in cancer screening and early detection.
A new screening program
will enroll 2,000 high-risk individuals over a three-year period with a two-year follow-up.
The OVCARE program
includes the use of an innovative microscope to unravel the genetic changes that give rise to ovarian cancers and pinpoint when in the development of these cancers they begin to change and become dangerous.